2-Jul-2026
KORU Medical Amends Long-Term Manufacturing and Supply Agreement
TipRanks (Tue, 30-Jun 5:18 PM ET)
Business Wire (Mon, 18-May 4:05 PM ET)
KORU Medical Systems Announces First Quarter 2026 Results
Business Wire (Wed, 6-May 4:05 PM ET)
KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026
Business Wire (Thu, 16-Apr 8:00 AM ET)
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
Koru Medical Systems trades on the NASDAQ stock market under the symbol KRMD.
As of July 2, 2026, KRMD stock price climbed to $4.49 with 114,661 million shares trading.
KRMD has a beta of 0.79, meaning it tends to be less sensitive to market movements. KRMD has a correlation of 0.05 to the broad based SPY ETF.
KRMD has a market cap of $206.24 million. This is considered a Small Cap stock.
Last quarter Koru Medical Systems reported $12 million in Revenue and $.00 earnings per share. This beat revenue expectation by $467,240 and exceeded earnings estimates by $.01.
In the last 3 years, KRMD traded as high as $6.61 and as low as $1.86.
The top ETF exchange traded funds that KRMD belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
KRMD has outperformed the market in the last year with a price return of +23.4% while the SPY ETF gained +21.3%. However, in the short term, KRMD had mixed performance relative to the market. It has underperformed in the last 3 months, returning +3.9% vs +13.9% return in SPY. But in the last 2 weeks, KRMD shares have fared better than the market returning +15.1% compared to SPY -0.3%.
KRMD support price is $4.23 and resistance is $4.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KRMD shares will trade within this expected range on the day.